# Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

> **NCT05573282** · — · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Regorafenib combine with ICIs

## Key facts

- **NCT ID:** NCT05573282
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-16
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573282, "Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05573282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*